• Media type: E-Article
  • Title: Transgenic Eimeria tenella as a vaccine vehicle: expressing TgSAG1 elicits protective immunity against Toxoplasma gondii infections in chickens and mice
  • Contributor: Tang, Xinming; Yin, Guangwen; Qin, Mei; Tao, Geru; Suo, Jingxia; Liu, Xianyong; Suo, Xun
  • imprint: Springer Science and Business Media LLC, 2016
  • Published in: Scientific Reports
  • Language: English
  • DOI: 10.1038/srep29379
  • ISSN: 2045-2322
  • Keywords: Multidisciplinary
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:p>The surface antigen 1 of <jats:italic>Toxoplasma gondii</jats:italic> (TgSAG1) is a major immunodominant antigen and is widely considered an ideal candidate for the development of an effective recombinant vaccine against toxoplasmosis. <jats:italic>Eimeria tenella</jats:italic>, an affinis apicomplexan parasite with <jats:italic>T. gondii</jats:italic>, is a potential vaccine vector carrying exogenous antigens that stimulates specific immune responses. Here, we engineered TgSAG1 into <jats:italic>E. tenella</jats:italic> and obtained a stably transfected <jats:italic>E. tenella</jats:italic> line (Et-TgSAG1). We found TgSAG1 localized on the cell surface of Et-TgSAG1, which is similar to its native distribution in <jats:italic>T. gondii</jats:italic> tachyzoites. We immunized the chickens with Et-TgSAG1 orally and detected TgSAG1-specific immune responses, which partly reduced <jats:italic>T. gondii</jats:italic> infection. In the mouse model, we immunized the mice with Et-TgSAG1 sporozoites intraperitoneally and challenged them with <jats:italic>T. gondii</jats:italic> tachyzoites RH strain. We found that the mice immunized with Et-TgSAG1 showed a TgSAG1 specific Th 1-dominant immune response and a prolonged survival time compared with wild-type <jats:italic>E. tenella</jats:italic> and non-immunized mice. Collectively, our results demonstrated that Et-TgSAG1, utilized as a recombinant vaccine against toxoplasmosis, could be applied in both chickens and mice. Our findings also provide a promising persuasion for the development of transgenic <jats:italic>Eimeria</jats:italic> as vaccine vectors for use in birds and mammals.</jats:p>
  • Access State: Open Access